FDA OK’s AquAdvantage Salmon
News Nov 23, 2015
The FDA scientists rigorously evaluated extensive data submitted by the manufacturer, AquaBounty Technologies, and other peer-reviewed data, to assess whether AquAdvantage salmon met the criteria for approval established by law; namely, safety and effectiveness. The data demonstrated that the inserted genes remained stable over several generations of fish, that food from the GE salmon is safe to eat by humans and animals, that the genetic engineering is safe for the fish, and the salmon meets the sponsor’s claim about faster growth.
In addition, FDA assessed the environmental impacts of approving this application and found that the approval would not have a significant impact on the environment of the United States. That’s because the multiple containment measures the company will use in the land-based facilities in Panama and Canada make it extremely unlikely that the fish could escape and establish themselves in the wild.
Official limits are in place regarding the levels of a multitude of substances that are deemed to be safe and acceptable in drinking water, but to fulfill these requirements analysts need the tools to enable them to do this. We spoke to Yan Liu, and Katariina Majamaa from Thermo Fisher Scientific about their new columns designed to enable rapid separations of contaminants prior to analysis using ion chromatography-mass spectrometry (IC-MS).READ MORE